As Affymetrix datasets (www.oncomine.org) showed that clusterin mRNA expression was low in advanced metastatic cancers [18], we measured clusterin immunofluorescence in non-tumorous pituitary tissue, and in pituitary adenoma cell types (Figure 3). Here, CLU is linked to metastatic malignant neoplasm.